Streetbeat News

Equity Actions

SPRC

SciSparc shares declined following the announcement of a Standby Equity Agreement with a Selling Shareholder, allowing for the sale of up to $20 million in Ordinary Shares.

Portfolio Pulse from Benzinga Newsdesk

August 29, 2024 | 4:03 pm

ENSC

Ensysce Biosciences (ENSC) shares dropped 30% after announcing a $5 million direct offering and private placement. The company issued shares and warrants at a reduced price to fund its programs and working capital. Despite the drop, ENSC has outperformed its historical averages.

Portfolio Pulse from Henry Khederian

August 29, 2024 | 3:10 pm

BBY

Best Buy has revised its financial expectations for 2025, increasing its share repurchase plan to $500 million from the previous $350 million, while reducing its capital expenditure forecast to $750 million from $800 million.

Portfolio Pulse from Benzinga Newsdesk

August 29, 2024 | 2:45 pm

TCS

The Container Store's shares are trading lower following the company's approval of a 1-for-15 reverse stock split.

Portfolio Pulse from Benzinga Newsdesk

August 29, 2024 | 2:23 pm

HPQ

HP shares rose after the company reported strong Q3 results and increased its share repurchase authorization to $10 billion. The stock initially fell but later recovered.

Portfolio Pulse from Benzinga Newsdesk

August 29, 2024 | 2:06 pm

AILE

BCDA

BIG

LUCY

NVDA

U.S. stocks rose with the Dow gaining over 100 points. Nvidia reported strong earnings and announced a $50 billion stock repurchase. BioCardia and Innovative Eyewear shares surged after positive news, while iLearningEngines and Big Lots faced declines due to negative reports.

Portfolio Pulse from Avi Kapoor

August 29, 2024 | 2:00 pm

SPRC

SciSparc has filed for the sale of up to 21 million ordinary shares under a $20 million SEPA agreement, with shares priced at 97% of market value. The company may receive up to $8.82 million from this sale.

Portfolio Pulse from Benzinga Newsdesk

August 29, 2024 | 12:46 pm

BZ

KANZHUN shares rose following the announcement of an additional $150 million share repurchase authorization, adding to its existing $200 million buyback plan.

Portfolio Pulse from Benzinga Newsdesk

August 29, 2024 | 12:37 pm

CANF

Can-Fite BioPharma reported a slight decrease in revenue for the first half of 2024 compared to 2023, with a net loss reduction due to lower operating expenses. The company entered into a warrant exercise agreement, raising $5 million in gross proceeds.

Portfolio Pulse from Benzinga Newsdesk

August 29, 2024 | 12:21 pm

ENSC

Ensysce Biosciences shares declined following the announcement of a $5 million registered direct offering and concurrent private placement.

Portfolio Pulse from Benzinga Newsdesk

August 29, 2024 | 12:14 pm